These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1966332)

  • 1. [Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture].
    Deng J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):330-4. PubMed ID: 1966332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of 1,25-(OH)2D3 on the secretion of growth hormone by human pituitary growth hormone-secreting tumors in vitro].
    Deng J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Jun; 14(3):210-4. PubMed ID: 1327564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of GRH mediated AC-cAMP system in the pathogenesis of human pituitary GH-secreting adenomas.
    Shi Y; Deng J; Yin J
    Chin Med J (Engl); 1996 Aug; 109(8):603-8. PubMed ID: 9206060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.
    Lamberts SW; Verleun T; Hofland L; Del Pozo E
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):11-23. PubMed ID: 2888550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion.
    Lamberts SW; Verleun T; Zuiderwijk JM; Oosterom R
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
    Johansen PW; Haug E; Gautvik KM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
    García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
    Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro.
    Renner U; Mojto J; Lange M; Müller OA; von Werder K; Stalla GK
    Eur J Endocrinol; 1994 Jan; 130(1):80-91. PubMed ID: 8124483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    Hofland LJ; de Herder WW; Waaijers M; Zuijderwijk J; Uitterlinden P; van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester and phospholipase C-induced growth hormone secretion from pituitary somatotroph adenoma cells in culture: effects of somatostatin, bromocriptine, and pertussis toxin.
    Ikuyama S; Nawata H; Kato K; Natori S; Ibayashi H
    J Clin Endocrinol Metab; 1987 Mar; 64(3):572-7. PubMed ID: 2880863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of Ca2+ in the pathogenesis of human pituitary GH-secreting adenomas].
    Yin J; Deng J; Shi Y; Shu C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Feb; 18(1):23-8. PubMed ID: 9208583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytocidal effects of bromocriptine, somatostatin analog, and heat on growth hormone-secreting pituitary adenoma in vitro.
    Kawamoto K; Uozumi T; Sakoda K; Mukada K; Kurisu K; Yano T
    Cancer; 1992 Jun; 69(11):2688-96. PubMed ID: 1571899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas.
    Spada A; Sartorio A; Bassetti M; Pezzo G; Giannattasio G
    J Clin Endocrinol Metab; 1982 Oct; 55(4):734-40. PubMed ID: 7107817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.
    Bression D; Brandi AM; Nousbaum A; Le Dafniet M; Racadot J; Peillon F
    J Clin Endocrinol Metab; 1982 Sep; 55(3):589-93. PubMed ID: 7096541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.